Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Julphar
Dow
Fish and Richardson
Baxter
Medtronic
Colorcon
UBS
Mallinckrodt
Teva

Generated: January 22, 2019

DrugPatentWatch Database Preview

Drugs in Development Information for Tafamidis

« Back to Dashboard

US Patents for Tafamidis

Drugname Patent Number Patent Title Patent Assignee Estimated Expiration
Tafamidis ➤ Sign Up Compositions and methods for stabilizing transthyretin and inhibiting transthyretin misfolding The Scripps Research Institute (La Jolla, CA) ➤ Sign Up
Tafamidis ➤ Sign Up Compositions and methods for stabilizing transthyretin and inhibiting transthyretin misfolding The Scripps Research Institute (La Jolla, CA) ➤ Sign Up
Tafamidis ➤ Sign Up Methods for treating transthyretin amyloid diseases The Scripps Research Institute (La Jolla, CA) ➤ Sign Up
Tafamidis ➤ Sign Up Pharmaceutically acceptable salt of 6-carboxy-2-(3,5 dichlorophenyl)-benzoxazole, and a pharmaceutical composition comprising the salt thereof The Scripps Research Institute (La Jolla, CA) ➤ Sign Up
Tafamidis ➤ Sign Up Compound and use thereof in the treatment of amyloidosis Pentraxin Therapeutics Ltd. (London, GB) ➤ Sign Up
Tafamidis ➤ Sign Up Methods for treating transthyretin amyloid diseases The Scripps Research Institute (La Jolla, CA) ➤ Sign Up
Drugname Patent Number Patent Title Patent Assignee Estimated Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

International Patents for Tafamidis

Drugname Country Document Number Estimated Expiration Related US Patent
Tafamidis Austria 405840 2022-12-19 ➤ Sign Up
Tafamidis Austria 524741 2022-12-19 ➤ Sign Up
Tafamidis Australia 2003303196 2022-12-19 ➤ Sign Up
Tafamidis Australia 2010201263 2022-12-19 ➤ Sign Up
Tafamidis Brazil 0317463 2022-12-19 ➤ Sign Up
Tafamidis Brazil PI0317463 2022-12-19 ➤ Sign Up
Drugname Country Document Number Estimated Expiration Related US Patent

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

US Army
Healthtrust
UBS
Federal Trade Commission
US Department of Justice
Mallinckrodt
Daiichi Sankyo
McKinsey
Argus Health

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.